The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Parathyroid Disorders-Global Market Insights and Sales Trends 2024
Synopsis
Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
The global Parathyroid Disorders market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parathyroid Disorders in various end use industries. The expanding demands from the Hospitals, Specialty Clinic and Others,, are propelling Parathyroid Disorders market. Hyperparathyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parathyroid Cancer segment is estimated at % CAGR for the next seven-year period.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parathyroid Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parathyroid Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parathyroid Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parathyroid Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parathyroid Disorders covered in this report include Abbott Laboratories, Alcon Laboratories, Amgen, Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly and Ethicon, etc.
The global Parathyroid Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
Global Parathyroid Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parathyroid Disorders market, Segment by Type:
Hyperparathyroidism
Parathyroid Cancer
Hypoparathyroidism
Global Parathyroid Disorders market, by Application
Hospitals
Specialty Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parathyroid Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
The global Parathyroid Disorders market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parathyroid Disorders in various end use industries. The expanding demands from the Hospitals, Specialty Clinic and Others,, are propelling Parathyroid Disorders market. Hyperparathyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parathyroid Cancer segment is estimated at % CAGR for the next seven-year period.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parathyroid Disorders, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parathyroid Disorders market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parathyroid Disorders market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parathyroid Disorders sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parathyroid Disorders covered in this report include Abbott Laboratories, Alcon Laboratories, Amgen, Bayer Healthcare, Becton, Dickinson and Company, Eli Lilly and Ethicon, etc.
The global Parathyroid Disorders market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
Global Parathyroid Disorders market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parathyroid Disorders market, Segment by Type:
Hyperparathyroidism
Parathyroid Cancer
Hypoparathyroidism
Global Parathyroid Disorders market, by Application
Hospitals
Specialty Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parathyroid Disorders companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Parathyroid Disorders
1.1 Parathyroid Disorders Market Overview
1.1.1 Parathyroid Disorders Product Scope
1.1.2 Parathyroid Disorders Market Status and Outlook
1.2 Global Parathyroid Disorders Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Parathyroid Disorders Market Size by Region (2018-2029)
1.4 Global Parathyroid Disorders Historic Market Size by Region (2018-2023)
1.5 Global Parathyroid Disorders Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Parathyroid Disorders Market Size (2018-2029)
1.6.1 North America Parathyroid Disorders Market Size (2018-2029)
1.6.2 Europe Parathyroid Disorders Market Size (2018-2029)
1.6.3 Asia-Pacific Parathyroid Disorders Market Size (2018-2029)
1.6.4 Latin America Parathyroid Disorders Market Size (2018-2029)
1.6.5 Middle East & Africa Parathyroid Disorders Market Size (2018-2029)
2 Parathyroid Disorders Market by Type
2.1 Introduction
2.1.1 Hyperparathyroidism
2.1.2 Parathyroid Cancer
2.1.3 Hypoparathyroidism
2.2 Global Parathyroid Disorders Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Parathyroid Disorders Historic Market Size by Type (2018-2023)
2.2.2 Global Parathyroid Disorders Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Parathyroid Disorders Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Parathyroid Disorders Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Parathyroid Disorders Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Parathyroid Disorders Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Parathyroid Disorders Revenue Breakdown by Type (2018-2029)
3 Parathyroid Disorders Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinic
3.1.3 Others
3.2 Global Parathyroid Disorders Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Parathyroid Disorders Historic Market Size by Application (2018-2023)
3.2.2 Global Parathyroid Disorders Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Parathyroid Disorders Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Parathyroid Disorders Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Parathyroid Disorders Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Parathyroid Disorders Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Parathyroid Disorders Revenue Breakdown by Application (2018-2029)
4 Parathyroid Disorders Competition Analysis by Players
4.1 Global Parathyroid Disorders Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parathyroid Disorders as of 2022)
4.3 Date of Key Players Enter into Parathyroid Disorders Market
4.4 Global Top Players Parathyroid Disorders Headquarters and Area Served
4.5 Key Players Parathyroid Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Parathyroid Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Parathyroid Disorders Products, Services and Solutions
5.1.4 Abbott Laboratories Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Alcon Laboratories
5.2.1 Alcon Laboratories Profile
5.2.2 Alcon Laboratories Main Business
5.2.3 Alcon Laboratories Parathyroid Disorders Products, Services and Solutions
5.2.4 Alcon Laboratories Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.2.5 Alcon Laboratories Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Parathyroid Disorders Products, Services and Solutions
5.3.4 Amgen Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Healthcare Recent Developments
5.4 Bayer Healthcare
5.4.1 Bayer Healthcare Profile
5.4.2 Bayer Healthcare Main Business
5.4.3 Bayer Healthcare Parathyroid Disorders Products, Services and Solutions
5.4.4 Bayer Healthcare Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Healthcare Recent Developments
5.5 Becton, Dickinson and Company
5.5.1 Becton, Dickinson and Company Profile
5.5.2 Becton, Dickinson and Company Main Business
5.5.3 Becton, Dickinson and Company Parathyroid Disorders Products, Services and Solutions
5.5.4 Becton, Dickinson and Company Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.5.5 Becton, Dickinson and Company Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Parathyroid Disorders Products, Services and Solutions
5.6.4 Eli Lilly Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Ethicon
5.7.1 Ethicon Profile
5.7.2 Ethicon Main Business
5.7.3 Ethicon Parathyroid Disorders Products, Services and Solutions
5.7.4 Ethicon Parathyroid Disorders Revenue (US$ Million) & (2018-2023)
5.7.5 Ethicon Recent Developments
6 North America
6.1 North America Parathyroid Disorders Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Parathyroid Disorders Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Parathyroid Disorders Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Parathyroid Disorders Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Parathyroid Disorders Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Parathyroid Disorders Market Dynamics
11.1 Parathyroid Disorders Industry Trends
11.2 Parathyroid Disorders Market Drivers
11.3 Parathyroid Disorders Market Challenges
11.4 Parathyroid Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
